Plaque Psoriasis
Symptoms, Doctors, Treatments, Advances & More

Plaque Psoriasis Overview

Save information for later
Sign Up

Learn About Plaque Psoriasis

What is the definition of Plaque Psoriasis?
Plaque psoriasis is the most common form of psoriasis. Psoriasis is an autoimmune skin disorder that affects the growth rate of skin cells. Plaque psoriasis causes raised, reddened dry skin patches with silvery scales that appear on the scalp, elbows, knees, trunk and back.
What are the symptoms of Plaque Psoriasis?
Plaque psoriasis appears in cycles, with periods of remission followed by flare-ups that can last from weeks to months. Symptoms of plaque psoriasis during flare-ups can include reddened, dry skin patches covered in thick silvery scales, usually on the elbows, arms, knees, abdomen, and back, that may cause itching, burning, or bleeding. The sizes of the psoriasis plaques can range from small spots to covering large areas of the body. Nearly half of patients with psoriasis also have abnormal, thickened nails that are pitted or ridged. Psoriasis can also affect the mouth or genitals.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Plaque Psoriasis?
There is currently no cure for plaque psoriasis. Treatments for plaque psoriasis include topical therapy, such as corticosteroids, Vitamin D analogues, retinoids, calcineurin inhibitors, salicylic acid, coal tar, Goeckerman therapy, and anthralin; light therapy; other oral or injected medications; biologics; and alternative therapies.
Who are the top Plaque Psoriasis Local Doctors?
Andrew Blauvelt
Elite in Plaque Psoriasis
Dr. Andrew Blauvelt
Dermatology
Elite in Plaque Psoriasis
Dr. Andrew Blauvelt
Dermatology

James W. Baker MD LLC

9495 SW Locust St Ste A, 
Portland, OR 
503-445-2200
Languages Spoken:
English
See accepted insurances

Andrew Blauvelt is a Dermatologist in Portland, Oregon. Dr. Blauvelt is rated as an Elite provider by MediFind in the treatment of Plaque Psoriasis. His top areas of expertise are Plaque Psoriasis, Psoriasis, Atopic Dermatitis, and Actinic Keratosis.

Stephen Tyring
Elite in Plaque Psoriasis
Dr. Stephen Tyring
Dermatology
Elite in Plaque Psoriasis
Dr. Stephen Tyring
Dermatology

Houston Skin Cancer Associates PLLC

451 N Texas Ave, 
Webster, TX 
281-333-3376
Languages Spoken:
English
See accepted insurances

Stephen Tyring is a Dermatologist in Webster, Texas. Dr. Tyring is rated as an Elite provider by MediFind in the treatment of Plaque Psoriasis. His top areas of expertise are Shingles, Plaque Psoriasis, Psoriasis, and Warts.

 
 
 
 
Learn about our expert tiers
Learn More
Laura Ferris
Elite in Plaque Psoriasis
Dr. Laura Ferris
Dermatology
Elite in Plaque Psoriasis
Dr. Laura Ferris
Dermatology

Office

3601 5th Ave Ste 5A, 
Pittsburgh, PA 
412-647-4200
Languages Spoken:
English
See accepted insurances

Laura Ferris is a Dermatologist in Pittsburgh, Pennsylvania. Dr. Ferris is rated as an Elite provider by MediFind in the treatment of Plaque Psoriasis. Her top areas of expertise are Psoriasis, Plaque Psoriasis, Melanoma, and Familial Atypical Multiple Mole Melanoma Syndrome.

View All Doctors
What are the latest Plaque Psoriasis Clinical Trials?
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial
Enrollment Status: Recruiting
Publish Date: February 11, 2026
Intervention Type: Drug
Study Phase: Phase 4

Summary: This study will evaluate the effects of oral semaglutide in combination with topical corticosteroid/calcipotriol on clinical outcomes and metabolic inflammation in patients with plaque psoriasis and overweight/obesity and/or type 2 diabetes mellitus. A total of 62 participants will be randomized to receive either semaglutide plus topical corticosteroid/calcipotriol or placebo plus topical corticos...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3b/4 Multi-center, Randomized, Open-label, Long-term Safety Study of Deucravacitinib in Comparison to Ustekinumab in Participants With Moderate-to-Severe Plaque Psoriasis
A Phase 3b/4 Multi-center, Randomized, Open-label, Long-term Safety Study of Deucravacitinib in Comparison to Ustekinumab in Participants With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Recruiting
Publish Date: February 10, 2026
Intervention Type: Drug
Study Phase: Phase 3

Summary: A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis

View All Clinical Trials